Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) price on current trading day, fall -1.54% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $19.23.
A look at the stock’s price movement, the close in the last trading session was $19.53. Turning to its 52-week performance, $36.72 and $17.05 were the 52-week high and 52-week low respectively. Overall, ARWR moved -5.04% over the past month.
Arrowhead Pharmaceuticals Inc’s market cap currently stands at around $2.42 billion, with investors looking forward to this quarter’s earnings report slated for in March.
Wall Street analysts have also projected the company’s year-on-year revenue to grow to 291.34M, representing a 8,104.36% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ARWR is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
9 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 3 analyst(s) rate the stock as a Hold, 6 recommend ARWR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ARWR’s current price about -2.86% and -3.12% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 46.01, while 7-day volatility ratio is 5.90% and 5.40% in the 30-day chart. Further, Arrowhead Pharmaceuticals Inc (ARWR) has a beta value of 0.92, and an average true range (ATR) of 1.12. Analysts have given the company’s stock an average 52-week price target of $27, forecast between a low of $24 and high of $29.97. Looking at the price targets, the low is -24.8% off current price level while to achieve the yearly target high, price needs to move -55.85%. Nonetheless, investors will most likely welcome a -40.41% jump to $27 which is the analysts’ median price.
If we refocus on Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR), historical trading data shows that trading volumes averaged 2.09 million over the past 3 months. The company’s latest data on shares outstanding shows there are 125.57 million shares.
The 7.24% of Arrowhead Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 77.04% of the company’s shares. Current price change has pushed the stock 2.29% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ARWR stock continues to rise going into the next quarter.
